The receptor tyrosine kinase ROR1 – An oncofetal antigen for targeted cancer therapyMohammad Hojjat‐Farsangi, Håkan Mellstedt, Ali Moshfegh et al.|Seminars in Cancer Biology|2014Cited by 99
The Tyrosine Kinase Receptor ROR1 Is Constitutively Phosphorylated in Chronic Lymphocytic Leukemia (CLL) CellsMohammad Hojjat‐Farsangi, Håkan Mellstedt, Abdul Salam Khan et al.|PLoS ONE|2013Cited by 60
First-in-class oral small molecule inhibitor of the tyrosine kinase ROR1 (KAN0439834) induced significant apoptosis of chronic lymphocytic leukemia cellsMohammad Hojjat‐Farsangi, Ali Moshfegh, Amir Hossein Daneshmanesh et al.|Leukemia|2018Cited by 52
A receptor tyrosine kinase ROR1 inhibitor (KAN0439834) induced significant apoptosis of pancreatic cells which was enhanced by erlotinib and ibrutinibAmir Hossein Daneshmanesh, Håkan Mellstedt, Mohammad Hojjat‐Farsangi et al.|PLoS ONE|2018Cited by 43
The PI3K/AKT/mTOR pathway is involved in direct apoptosis of CLL cells induced by ROR1 monoclonal antibodiesAmir Hossein Daneshmanesh, Håkan Mellstedt, Mohammad Hojjat‐Farsangi et al.|British Journal of Haematology|2014Cited by 39